ExLibris header image
SFX Logo
Title: Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Source:

Nature Communications [2041-1723] Obregon, Demian yr:2012


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Robert, M. "Tau and tauopathies." Neurology, India 55.1 (2007): 11-6. Link to Full Text for this item Link to SFX for this item
2. Pittman, Alan M M. "Untangling the tau gene association with neurodegenerative disorders." Human Molecular Genetics 15.2 (2006): 188-95. Link to SFX for this item
3. Moreno, J. "Tau phosphorylation, aggregation, and cell toxicity." Journal of biomedicine and biotechnology 2006.3 (2006): 1-. Link to Full Text for this item Link to SFX for this item
4. Deutsch, Stephen I I. "Dysregulation of tau phosphorylation is a hypothesized point of convergence in the pathogenesis of Alzheimer's disease, frontotemporal dementia and schizophrenia with therapeutic implications." Progress in neuro-psychopharmacology & biological psychiatry 30.8 (2006): 1369-1380. Link to SFX for this item
5. De Deyn, C. "Galantamine treatment of vascular dementia: a randomized trial." Neurology 69.5 (2007): 448-58. Link to SFX for this item
6. Avila, J. "Tauopathies." Cellular and molecular life sciences 64.17 (2007): 2219-2233. Link to Full Text for this item Link to SFX for this item
7. Leung, A. "The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts." Neurobiology of disease 25.3 (2007): 561-70. Link to SFX for this item
8. Williams, D. "Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau." Internal medicine journal 36.10: 652-660. Link to SFX for this item
9. Kavirajan, H.. "Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials." Lancet. Neurology 6.9 (2007): 782-792. Link to SFX for this item
10. Trojanowski, Carlo Q. "Tau-mediated neurodegeneration in Alzheimer's disease and related disorders." Nature reviews. Neuroscience 8.9 (2007): 663-672. Link to Full Text for this item Link to SFX for this item
11. Halliday, Glenda M M. "Neuropathology in the S305S tau gene mutation." Brain 129.Pt 3 (2006). Link to SFX for this item
12. Sha, S. "Are frontotemporal lobar degeneration, progressive supranuclear palsy and corticobasal degeneration distinct diseases?" Nature clinical practice neurology 2.12 (2007): 658-65. Link to Full Text for this item Link to SFX for this item
13. Pastorino, L. "Pathogenic mechanisms in Alzheimer's disease." European Journal of Pharmacology 545.1 (2006): 29-38. Link to SFX for this item
14. Gershoff, Elizabeth T. "MORE HARM THAN GOOD: A SUMMARY OF SCIENTIFIC RESEARCH ON THE INTENDED AND UNINTENDED EFFECTS OF CORPORAL PUNISHMENT ON CHILDREN." Law and contemporary problems 73.2 (2010): 31-56. Link to SFX for this item
15. Binder, Lester I. "Tau, tangles, and Alzheimer's disease." Biochimica et biophysica acta. Molecular basis of disease 1739.2-3 (2005): 216-223. Link to SFX for this item
16. Avila, J. "Tau phosphorylation and aggregation in Alzheimer's disease pathology." FEBS letters 580.12 (2006): 2922-2927. Link to Full Text for this item Link to SFX for this item
17. Okugawa, G. "Neural disorganization in the superior cerebellar peduncle and cognitive abnormality in patients with schizophrenia: A diffusion tensor imaging study." Progress in neuro-psychopharmacology & biological psychiatry 30.8 (2006): 1408-1412. Link to SFX for this item
18. Blesa, R. "Effect of butyrylcholinesterase genotype on the response to rivastigmine or donepezil in younger patients with Alzheimer's disease." Pharmacogenetics and genomics 16.11 (2006): 771-4. Link to SFX for this item
19. Nelson, Nathaniel W W. "Differential diagnosis of Alzheimer's dementia and vascular dementia." Disease-a-month 53.3 (2007): 148-51. Link to SFX for this item
20. Mirski, D. "A pilot study evaluating the efficacy and safety of rivastigmine in patients with mixed dementia." Drugs & aging 23.3 (2006): 241-249. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.